SCHEMBL3828337

SCHEMBL3828337

CCOC(=O)CN1CCN(C(=O)O)C[C@@H]1C

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.40
SLC6A9 P48067 2/20 0.36
HSD11B1 P28845 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
ALDH1A1 P00352 5/20 0.35
POLB P06746 2/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
KDM4E B2RXH2 1/20 0.34
DRD3 P35462 1/20 0.34
MGLL Q99685 1/20 0.34
ELANE P08246 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3832320 1.00 CHRM1 (0.40) CHRM1SLC6A9HSD11B1SIGMAR1ALDH1A1
SCHEMBL3832656 0.85 HRH3 (0.42) CHRM1ALDH1A1POLBHTTSMN1; SMN2
SCHEMBL3832651 0.85 HRH3 (0.42) CHRM1ALDH1A1POLBHTTSMN1; SMN2
SCHEMBL20236007 0.84 DRD3 (0.38) CHRM1SLC6A9SIGMAR1POLBTSHR
SCHEMBL13567958 0.82 GPR119 (0.39) ALDH1A1SMN1; SMN2KDM4ERECQL
SCHEMBL13567937 0.82 GPR119 (0.39) ALDH1A1SMN1; SMN2KDM4ERECQL
SCHEMBL13868417 0.82 MGAM (0.44) HSD11B1SIGMAR1ALDH1A1GSK3AGSK3B
SCHEMBL26093906 0.81 DPP4 (0.39) ALDH1A1POLBGSK3AGSK3BHTT
SCHEMBL26093912 0.81 DPP4 (0.39) ALDH1A1POLBGSK3AGSK3BHTT
SCHEMBL19133709 0.80 TSHR (0.33) ALDH1A1POLBGSK3AGSK3BHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132483-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2024-04-25 US disclosed
US-11858916-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2024-01-02 US disclosed
EP-3806855-B1 GLP-1 RECEPTOR AGONISTS AND USES THEREOF PFIZER (US) 2023-03-01 EP disclosed
US-20210332034-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2021-10-28 US disclosed
EP-3806855-A1 GLP-1 RECEPTOR AGONISTS AND USES THEREOF Pfizer Inc. (US) 2021-04-21 EP disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
EP-2103619-A1 IMIDAZOTHIAZOLE DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312310-A1 Imidazothiazole derivatives TP53, MDM2, TP53BP1 CHRM1 3151/4885SLC6A9 4838/4885HSD11B1 3978/4885
US-11858916-B2 GLP-1 receptor agonists and uses thereof GLP1R, GIPR, GCGR CHRM1 1223/4885SLC6A9 2804/4885HSD11B1 3189/4885
US-20240132483-A1 GLP-1 Receptor Agonists and Uses Thereof GLP1R, GIPR, GCGR CHRM1 1223/4885SLC6A9 2804/4885HSD11B1 3189/4885
US-20210332034-A1 GLP-1 Receptor Agonists and Uses Thereof GLP1R, GIPR, GCGR CHRM1 1223/4885SLC6A9 2804/4885HSD11B1 3189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.